Search results
Results from the WOW.Com Content Network
Guajira [ɡwaˈxi.ɾa] is a music genre derived from the punto cubano.According to some specialists, [1] the punto cubano was known in Spain since the 18th century, where it was called "punto de La Habana", and by the second half of the 19th century it was adopted by the incipient Spanish Flamenco style, which included it within its "palos" with the name of guajira. [2]
The Best of Santana Vol. 2 is a 2000 Compilation album by Santana and a companion album to 1998's ... "Guajira" "Everything's Coming Our Way" "Europa (Earth's Cry ...
Santana III was also the last Santana album to hit #1 on the charts until Supernatural in 1999. The 2005 edition of Guinness World Records stated that was the longest gap between #1 albums ever occurring (a record which is now held by Paul McCartney since his seventeenth solo studio album, Egypt Station , topped the Billboard 200 chart on 2018 ...
Sacred Fire: Live in South America is an album by Santana, released in 1993.This album is dedicated to the life of Cesar Chavez.The title, "Live in South America", is not correct, as the location of the concert production, Mexico City, is not located on the continent of South America.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The guajira is a prime example of so-called cantes de ida y vuelta. [ 2 ] [ 3 ] The flamenco guajira is the adaptation to Melos flamenco of the Cuban point, the peasant point, a genre that brings together a series of songs called Guajiros that are grown in the rural areas of the island of Cuba. [ 3 ]
In 1995, Padini Holdings Sdn Bhd became a public company limited by shares and changed its name to Padini Holdings Berhad. It was also listed on the Second Board of the Kuala Lumpur Stock Exchange. In 2000, Padini Dot Com Sdn Bhd was established to provide electronic business services and solutions for the group.
This strong market position generates substantial cash flows that support shareholder returns. Turning to the specifics, the pharmaceutical giant offers investors a 4.3% dividend yield backed by a ...